We are live on ! Find out more
WIC

Willis Investment Counsel Portfolio holdings

AUM $2.1B
1-Year Est. Return 24.61%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+24.61%
3 Year Est. Return
+53.31%
5 Year Est. Return
+71.06%
10 Year Est. Return
+188.9%
AUM
$2.1B
AUM Growth
+$267M
Cap. Flow
+$172M
Cap. Flow %
8.19%
Top 10 Hldgs %
28.16%
Holding
129
New
6
Increased
73
Reduced
28
Closed
4

Top Buys

Rank Stock Value
1
MSI icon
Motorola Solutions
MSI
+$13.6M
2
ABT icon
Abbott
ABT
+$13.3M
3
ACN icon
Accenture
ACN
+$12.4M
4
ADBE icon
Adobe
ADBE
+$11.7M
5
CSCO icon
Cisco
CSCO
+$5.24M

Sector Composition

Rank Sector Weight
1 Technology 26.66%
2 Healthcare 18.11%
3 Industrials 17.7%
4 Financials 8.4%
5 Consumer Discretionary 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
1
Cisco
CSCO
$428B
$104M 4.95%
884,202
+50,145
+6% +$5.24M
JNJ icon
2
Johnson & Johnson
JNJ
$671B
$78.6M 3.75%
309,486
+20,068
+7% +$4.68M
TXN icon
3
Texas Instruments
TXN
$232B
$70.6M 3.37%
237,001
-29,643
-11% -$8.22M
CAT icon
4
Caterpillar
CAT
$368B
$58.1M 2.77%
54,570
+4,884
+10% +$4.29M
CB icon
5
Chubb
CB
$134B
$55.5M 2.65%
162,875
+9,084
+6% +$2.96M
LMT icon
6
Lockheed Martin
LMT
$123B
$49M 2.34%
96,275
+5,036
+6% +$2.72M
PAYX icon
7
Paychex
PAYX
$44.5B
$46M 2.19%
467,688
+30,658
+7% +$2.9M
MSFT icon
8
Microsoft
MSFT
$3.79T
$45.2M 2.15%
121,147
+7,713
+7% +$3.12M
PFE icon
9
Pfizer
PFE
$164B
$43.8M 2.09%
1,818,508
+100,571
+6% +$2.63M
MRK icon
10
Merck
MRK
$376B
$40.2M 1.92%
312,767
-951
-0.3% -$111K
HD icon
11
Home Depot
HD
$317B
$39.8M 1.9%
112,868
+5,385
+5% +$1.75M
AFL icon
12
Aflac
AFL
$59.3B
$38.1M 1.81%
324,544
+22,364
+7% +$2.57M
FTNT icon
13
Fortinet
FTNT
$115B
$35.5M 1.69%
230,869
+34,630
+18% +$4M
XOM icon
14
ExxonMobil
XOM
$667B
$33.8M 1.61%
246,874
+17,093
+7% +$2.56M
HSY icon
15
Hershey
HSY
$35.2B
$33.5M 1.6%
190,740
+9,779
+5% +$1.84M
GNRC icon
16
Generac Holdings
GNRC
$10.8B
$33.4M 1.59%
113,995
-31,426
-22% -$7.87M
KEYS icon
17
Keysight
KEYS
$54.9B
$33.3M 1.59%
95,062
+14,069
+17% +$4.8M
ADP icon
18
Automatic Data Processing
ADP
$113B
$33.2M 1.58%
148,056
-400
-0.3% -$85.5K
ACN icon
19
Accenture
ACN
$118B
$33.1M 1.58%
265,973
+71,175
+37% +$12.4M
ETN icon
20
Eaton
ETN
$154B
$32.8M 1.56%
76,973
-100
-0.1% -$40.3K
PEP icon
21
PepsiCo
PEP
$191B
$32.4M 1.55%
239,514
+10,462
+5% +$1.56M
MDT icon
22
Medtronic
MDT
$119B
$32.4M 1.55%
414,539
+22,491
+6% +$1.81M
AAPL icon
23
Apple
AAPL
$4.79T
$32.2M 1.53%
111,285
+2,149
+2% +$615K
DGX icon
24
Quest Diagnostics
DGX
$26.4B
$32.1M 1.53%
151,500
-300
-0.2% -$58.9K
ABT icon
25
Abbott
ABT
$188B
$31.3M 1.49%
345,349
+146,000
+73% +$13.3M

Similar funds

Willis Investment Counsel's Q2 2026 Portfolio in Review

As of Q2 2026, Willis Investment Counsel held 129 positions worth $2.1B, up 15% from $1.83B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Willis Investment Counsel deployed $172M of net new capital in Q2 2026, opening 6 new positions and adding to 73 existing holdings. Its largest new stake was Motorola Solutions: 32,600 shares worth $13.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Texas Instruments, an estimated $8.22M trimmed.

  • Willis Investment Counsel's largest Q2 2026 buy was Motorola Solutions: 32,600 shares worth $13.5M.
  • Willis Investment Counsel added most to Abbott in Q2 2026, an estimated $13.3M increase.
  • Willis Investment Counsel's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $8.22M.
  • Willis Investment Counsel fully exited Vanguard Morningstar Small-Cap Value ETF in Q2 2026, selling an estimated $18.2M.
  • Willis Investment Counsel's ten largest holdings make up 28% of its $2.1B portfolio in Q2 2026.
  • Willis Investment Counsel opened 6 new positions and closed 4 in Q2 2026.
  • Willis Investment Counsel's portfolio value rose 15% quarter-over-quarter to $2.1B.

Based on Willis Investment Counsel's 13F filing for Q2 2026, filed 3 Aug 2026.